Literature DB >> 12846563

Heparin and calcium ions dramatically enhance antithrombin reactivity with factor IXa by generating new interaction exosites.

Tina Bedsted1, Richard Swanson, Yung-Jen Chuang, Paul E Bock, Ingemar Björk, Steven T Olson.   

Abstract

Blood coagulation factor IXa has been presumed to be regulated by the serpin, antithrombin, and its polysaccharide activator, heparin, but it has not been clear whether factor IXa is inhibited by the serpin with a specificity comparable to that for thrombin and factor Xa or what determinants govern this specificity. Here we show that antithrombin is essentially unreactive with factor IXa in the absence of heparin (k(ass) approximately 10 M(-1) s(-1)) but undergoes a remarkable approximately 1 million-fold enhancement in reactivity with this proteinase to the physiologically relevant range (k(ass) approximately 10(7) M(-1) s(-1)) when activated by heparin in the presence of physiologic levels of calcium. This rate enhancement is shown to derive from three sources: (i) allosteric activation of antithrombin by a sequence-specific heparin pentasaccharide (300-500-fold), (ii) allosteric activation of factor IXa by calcium ions (4-8-fold), and (iii) heparin bridging of antithrombin and factor IXa augmented by calcium ions (130-1000-fold depending on heparin chain length). Mutagenesis of P6-P3' reactive loop residues of antithrombin further reveals that the reactivity of the unactivated inhibitor is principally determined by the P1 Arg residue, whereas exosites outside the loop which are present on the activated serpin and on heparin are responsible for heparin enhancement of this reactivity. These results together with our previous findings demonstrate that exosites are responsible for the unusual specificity of antithrombin and heparin for three clotting proteases with quite distinct substrate specificities.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12846563     DOI: 10.1021/bi034363y

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  28 in total

1.  Structural and functional characterization of a highly specific serpin in the insect innate immunity.

Authors:  Sun Hee Park; Rui Jiang; Shunfu Piao; Bing Zhang; Eun-Hye Kim; Hyun-Mi Kwon; Xiao Ling Jin; Bok Luel Lee; Nam-Chul Ha
Journal:  J Biol Chem       Date:  2010-11-03       Impact factor: 5.157

2.  Probing the coagulation pathway with aptamers identifies combinations that synergistically inhibit blood clot formation.

Authors:  Kristin M Bompiani; Jens L Lohrmann; George A Pitoc; James W Frederiksen; George B Mackensen; Bruce A Sullenger
Journal:  Chem Biol       Date:  2014-07-24

Review 3.  Update on heparin: what do we need to know?

Authors:  Daniel S Weitz; Jeffrey I Weitz
Journal:  J Thromb Thrombolysis       Date:  2010-02       Impact factor: 2.300

4.  Role of the residues of the 39-loop in determining the substrate and inhibitor specificity of factor IXa.

Authors:  Likui Yang; Chandrashekhara Manithody; Shabir H Qureshi; Alireza R Rezaie
Journal:  J Biol Chem       Date:  2010-07-13       Impact factor: 5.157

Review 5.  Inhibitory serpins. New insights into their folding, polymerization, regulation and clearance.

Authors:  Peter G W Gettins; Steven T Olson
Journal:  Biochem J       Date:  2016-08-01       Impact factor: 3.857

Review 6.  Molecular mechanisms of antithrombin-heparin regulation of blood clotting proteinases. A paradigm for understanding proteinase regulation by serpin family protein proteinase inhibitors.

Authors:  Steven T Olson; Benjamin Richard; Gonzalo Izaguirre; Sophia Schedin-Weiss; Peter G W Gettins
Journal:  Biochimie       Date:  2010-06-02       Impact factor: 4.079

7.  The tissue factor requirement in blood coagulation.

Authors:  Thomas Orfeo; Saulius Butenas; Kathleen E Brummel-Ziedins; Kenneth G Mann
Journal:  J Biol Chem       Date:  2005-10-07       Impact factor: 5.157

8.  Interaction of antithrombin with sulfated, low molecular weight lignins: opportunities for potent, selective modulation of antithrombin function.

Authors:  Brian L Henry; Justin Connell; Aiye Liang; Chandravel Krishnasamy; Umesh R Desai
Journal:  J Biol Chem       Date:  2009-06-04       Impact factor: 5.157

9.  Kinetic characterization of the protein Z-dependent protease inhibitor reaction with blood coagulation factor Xa.

Authors:  Xin Huang; Richard Swanson; George J Broze; Steven T Olson
Journal:  J Biol Chem       Date:  2008-09-03       Impact factor: 5.157

10.  A novel allosteric pathway of thrombin inhibition: Exosite II mediated potent inhibition of thrombin by chemo-enzymatic, sulfated dehydropolymers of 4-hydroxycinnamic acids.

Authors:  Brian L Henry; Bernhard H Monien; Paul E Bock; Umesh R Desai
Journal:  J Biol Chem       Date:  2007-09-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.